Skip to content
EntityQ7833138· pop 14· linked from 236 articles

trametinib

Sign in to save

Also known as TMT212, GSK1120212, GSK1120212B, GSK212, JTP 74057, Mekinist®, trametinib dimethyl sulfoxide, GSK 1120212

Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma and glioma. It is a MEK inhibitor drug with anti-cancer activity. It inhibits MEK1 and MEK2. It is taken by mouth.

Key facts

Drug.PubChem
11707110
Drug.DrugBank
DB08911
Drug.image
Trametinib.svg
Drug.image_class
skin-invert-image
Drug.tradename
Mekinist, Spexotras
Drug.MedlinePlus
a613040
Drug.DailyMedID
Trametinib
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
L01
Drug.ATC_suffix
EE01
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.legal_EU
Rx-only
Drug.CAS_number
871700-17-3
Drug.ChemSpiderID
9881833
Drug.UNII
33E86K87QN
Drug.KEGG
D10175

via Wikipedia infobox

Research

3,090 papers

via PubMed

~5 min read

Encyclopedic overview

6 sections
Contents
  • Medical uses
  • History
  • Society and culture
  • Legal status
  • Research
  • References

{{Infobox drug | image = Trametinib.svg | image_class = skin-invert-image | alt = | caption =

| pronounce = | tradename = Mekinist, Spexotras | Drugs.com = | MedlinePlus = a613040 | DailyMedID = Trametinib | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = EE01

Excerpted from Wikipedia’s “trametinib” article, available under the CC BY-SA 4.0 licence.